Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

54.75 +0.93 (+1.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
Investors seeking growth at a reasonable cost should explore LANTHEUS HOLDINGS INC (NASDAQ:LNTH). 
Via Chartmill
Here Are My Top 2 Stocks to Buy in May
A deep value on a top real estate owner, and a surprisingly cheap high-growth healthcare tech company. 
Via The Motley Fool
Evaluating Lantheus Holdings: Insights From 5 Financial Analysts
 
Via Benzinga
LNTH Stock Earnings: Lantheus Holdings Beats EPS, Beats Revenue for Q1 2024
LNTH stock results show that Lantheus Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
NASDAQ:LNTH is not too expensive for the growth it is showing.
In the world of growth stocks, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) shines as a value proposition. 
Via Chartmill
NASDAQ:LNTH: a strong growth stock preparing for the next leg up?.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating. 
Via Chartmill
Lantheus Reports First Quarter 2024 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
2 Magnificent Stocks You Probably Never Heard Of
You might not have heard of these stocks, but they're worth putting on your radar. 
Via The Motley Fool
Investors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.
Via Chartmill
Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024
Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations. 
Via InvestorPlace
NASDAQ:LNTH is showing good growth, while it is not too expensive.
Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH. 
Via Chartmill
NASDAQ:LNTH, a strong growth stock, setting up for a breakout.
Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
NASDAQ:LNTH—A High-Growth Stock Gearing Up for Its Next Upward Move.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a strong growth stock, setting up for a breakout. 
Via Chartmill
In a market where value is scarce, NASDAQ:LNTH offers a refreshing opportunity with its solid fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying. 
Via Chartmill
Cramer Calls Datadog 'Dynamite,' Puts SoFi In Dog House: 'What The Heck Is Going On'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marvell Technology, Inc. (NASDAQ: MRVL) reported a mixed quarter. 
Via Benzinga
The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024
Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023. 
Via InvestorPlace
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH. 
Via Chartmill
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
From Lantheus Holdings, Inc.
Via GlobeNewswire
Assessing Lantheus Holdings: Insights From 4 Financial Analysts
 
Via Benzinga
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms 
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) appears to be flying under the radar despite its strong fundamentals. 
Via Chartmill
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. 
Via Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday. 
Via Benzinga
Topics Stocks
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank.
While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable. 
Via Chartmill
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings Scheduled For February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.